Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Tourette Syndrome Association and Psyadon Pharmaceuticals collaborate on ecopipam

May 16, 2011

BioFocus and Astellas Pharma sign target discovery agreement for CNS disorders

May 13, 2011

Halozyme and ViroPharma sign agreement to develop subcutaneous Cinryze formulation

May 12, 2011

Takeda acquires exclusive rights to fomepizole in Japan from Paladin Labs

May 11, 2011

Allos Therapeutics and Mundipharma to codevelop anticancer drug Folotyn

May 11, 2011

Sosei gains Japanese rights to antifungal agent Loramyc from BioAlliance

May 11, 2011

Albany Medical School and Aegis Therapeutics join to develop peptide against breast cancer

May 11, 2011

Merrimack regains rights to nanoliposomal irinotecan from PharmaEngine

May 10, 2011

TGen licenses selective histone deacetylase inhibitors to Oncoholdings

May 9, 2011

Pfizer returns R-343 rights to Rigel Pharmaceuticals

May 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...